Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk
DAIC
JANUARY 23, 2024
mg reduced the risk of cardiovascular death, MI or heart attack, ischemic stroke, or ischemia-driven coronary revascularization by 31% compared with placebo.34 The benefit was most significant in reducing the incidence of stroke and angina requiring revascularization.35 Published 2019 Feb 28. 12 Colchicine, 0.5 References: 1.
Let's personalize your content